Current Status and Prospects for Combination Therapy with Immune Checkpoint Inhibitors in the Treatment of Non-small Cell Lung Cancer with <i>EGFR</i> Mutations

Authors

Institutions

Publication Details

Journal
Haigan
Published
2025-02-20
DOI
https://doi.org/10.2482/haigan.65.12
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Current Status and Prospects for Combination Therapy with Immune Checkpoint Inhibitors in the Treatment of Non-small Cell Lung Cancer with EGFR Mutations

Yoshimasa Shiraishi
Haigan
Lung Cancer Treatments and Mutations
article

Current Status and Prospects for Combination Therapy with Immune Checkpoint Inhibitors in the Treatment of Non-small Cell Lung Cancer with EGFR Mutations

Yoshimasa Shiraishi
article en

Abstract

No abstract available for this paper.
HaiganVol. 65(1)
Kyushu University Hospital (JP)
Good health and well-being
Openalex Percentile: Top 95%
Lung Cancer Treatments and Mutations
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.